Business Context and Reporting Period
This Form 8-K is a Current Report filed by Organovo Holdings, Inc. (not Vivosim Labs, INC.) on March 27, 2025. The filing serves to disclose a business update issued via press release on the same date under Item 7.01 (Regulation FD Disclosure). The company is incorporated in Delaware and trades on The Nasdaq Stock Market under the symbol ONVO.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of a press release rather than a financial statement (10-K or 10-Q). No quantitative financial data is embedded in the provided text.
Material Changes
The filing indicates the issuance of a business update press release. The text does not detail specific material changes to operations, financial position, or strategy within the body of the 8-K itself; such details are contained in the attached Exhibit 99.1 (Press Release), which is not included in the input text.
Guidance, Outlook, and Risks
Management commentary, guidance, outlook, and specific risk factors are referenced as being contained within the press release furnished as Exhibit 99.1. The 8-K explicitly states that the information in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Verify the discrepancy between the requested company name ("Vivosim Labs, INC.") and the actual registrant ("Organovo Holdings, Inc.").
- Review the attached Exhibit 99.1 (Press Release dated March 27, 2025) for the actual business update details, as the 8-K body contains no operational specifics.
- Confirm the trading symbol ONVO on The Nasdaq Stock Market.
- Note that the information provided in this 8-K is not legally "filed" under Section 18 of the 1934 Act, limiting liability exposure for the statements made in the press release.